Active Diabetes, Hormones & Metabolism Plants, Animals & Ecology

IMES Integrating Metabolic and Endocrine Science: A Discovery Research Platform for the Study of Metabolic Health and Disease

In plain English

AI plain-English summary

Hormones—chemical messengers that travel at vanishingly low concentrations through the bloodstream—orchestrate how the body uses energy, stores fat, builds muscle, and decides when to feel hungry. When this coordination breaks down, the result is not a single faulty cell but a system-wide failure: obesity, Type 2 diabetes, fatty liver disease, thyroid disorders, or the wasting condition cachexia. These are disorders of the whole body, not just one organ, yet most research still works inside disciplinary silos—cell biologists in one lab, geneticists in another, clinicians in a third. This project builds a Discovery Research Platform that deliberately smashes those barriers. It will pull together data from human genetics, population studies, physiology, model organisms, and cellular experiments into a single, integrated resource. The goal is to let researchers trace a hormone’s effect from a receptor on a cell surface all the way to a person’s appetite or blood sugar. This is fundamental science—there is no immediate new drug or device. But past work of this integrative kind has revealed how hormones like leptin and GLP-1 work, discoveries that later became blockbuster treatments for diabetes and obesity.

View original technical description
Metabolism is the process by which organisms handle energy and the materials needed to grow, reproduce, and remain healthy. These processes require sophisticated coordination, largely provided by hormones, circulating at low concentrations and interacting with receptors with high affinity and specificity. As well as controlling the disposition of macronutrients, hormones act on the brain to control appetite and food intake. Dysfunction of these processes underpins highly prevalent disorders such as obesity, Type 2 diabetes, fatty liver disease, thyroid disorders, and cachexia, which are quintessentially disorders of systems, not simply cells. A major challenge to the field, both basic and translational, has been the requirement to work across many levels in cells, humans and model organisms and to meaningfully integrate data. Building on our exceptional track record, we propose to create a Discovery Research Platform (DRP) that will integrate information from cellular studies, model organisms, human genetic, physiological and population studies to break down barriers between classical disciplines and provide a rich resource for the research community. We will engineer the DRP to be a beacon for advances in research culture that value and support participants in their efforts to understand human integrative biology and exploit that knowledge for human benefit.

View the original record at the funder ↗

Researchers

Albert Koulman (EPMC Awardee)Antonio Vidal-Puig (EPMC Awardee)Claire Meek (EPMC Awardee)David Savage (EPMC Awardee)Fiona Gribble (EPMC Awardee)Jens Brüning (EPMC Awardee)John Perry (EPMC Awardee)Stephen O'Rahilly (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Deep multi-omic integration to understand inter-organ relationships that regulate systemic immunometabolism
Investigation of immunometabolism at the single cell level by integration of spatial and temporal multiomics
Harmonising and Unifying Blood Metabolomic Analysis Networks (HUMAN)
The metabolicMine project: integrated data and tools for the Common Metabolic Disease community.
Protometabolic pathways: exploring the chemical roots of systems biology

Original classification

Directed Call

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.